These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [What do large clinical trials learn us about cardiovascular and renal prevention in patients with type 2 diabetes mellitus and hypertension?]. Dussol B, Berland Y. Nephrol Ther; 2006 May; 2(2):51-74. PubMed ID: 16895717 [Abstract] [Full Text] [Related]
13. Cardiovascular risk factor management is poorer in diabetic patients with undiagnosed peripheral arterial disease than in those with known coronary heart disease or cerebrovascular disease. Results of a nationwide study in tertiary diabetes centres. González-Clemente JM, Piniés JA, Calle-Pascual A, Saavedra A, Sánchez C, Bellido D, Martín-Folgueras T, Moraga I, Recasens A, Girbés J, Sánchez-Zamorano MA, Mauricio D, PADiD Study Group. Diabet Med; 2008 Apr; 25(4):427-34. PubMed ID: 18341592 [Abstract] [Full Text] [Related]
14. Rationale, design and patient baseline characteristics of OlmeSartan and calcium antagonists randomized (OSCAR) study: a study comparing the incidence of cardiovascular events between high-dose angiotensin II receptor blocker (ARB) monotherapy and combination therapy of ARB with calcium channel blocker in Japanese elderly high-risk hypertensive patients (ClinicalTrials. gov no. NCT00134160). Ogawa H, Kim-Mitsuyama S, Jinnouchi T, Matsui K, Arakawa K. Hypertens Res; 2009 Jul; 32(7):575-80. PubMed ID: 19444280 [Abstract] [Full Text] [Related]
15. Tissue angiotensin-converting enzyme inhibitors for the prevention of cardiovascular disease in patients with diabetes mellitus without left ventricular systolic dysfunction or clinical evidence of heart failure: a pooled meta-analysis of randomized placebo-controlled clinical trials. Saha SA, Molnar J, Arora RR. Diabetes Obes Metab; 2008 Jan; 10(1):41-52. PubMed ID: 18095949 [Abstract] [Full Text] [Related]
20. [Medical treatment of patients with clinical peripheral arterial disease at hospital discharge: compliance with the French guidelines and changing practices (COPART I registry)]. Béraut E, Cambou JP, Guilhem JM, Vaysse N, Labro S, Séverac D, Boccalon H, Bura-Rivière A. J Mal Vasc; 2008 Feb; 33(1):1-11. PubMed ID: 18187280 [Abstract] [Full Text] [Related] Page: [Next] [New Search]